186
A. Khazaei et al. / Applied Catalysis A: General 386 (2010) 179–187
129.9, 134.0, 143.4, 152.5, 169.8; Anal. calcd. for C19H16ClNO2: C,
70.05; H, 4.95; N, 4.30. Found: C, 70.25; H, 4.87; N, 4.24.
3.3.18. N-[(4-Formylphenyl)(2-hydroxynaphthalen-1-
yl)methyl]acetamide (2c)
Pale yellow solid; mp 237–240 ◦C; IR (KBr): 3390, 3207, 3057,
1700, 1628, 1607, 1278, 819 cm−1 1H NMR (300 MHz, DMSO-d6):
;
3.3.12. N-[(2-Hydroxynaphthalen-1-yl)(2-
chlorophenyl)methyl]acetamide (1l)
ı (ppm) 2.02 (s, 3H), 6.91–7.39 (m, 6H), 7.79–7.82 (m, 4H), 8.41 (d,
J = 6.6 Hz, 1H), 8.56 (d, J = 7.6 Hz, 1H), 9.93 (s, 1 H), 10.10 (s, 1 H); 13
C
White solid; mp 197–199 ◦C (lit. [24] 194–196 ◦C); 1H NMR
(300 MHz, DMSO-d6): ı (ppm) 2.01 (s, 3H), 6.97–6.43 (m, 8H),
7.68–7.76 (m, 2H), 8.16–8.22 (m, 2H), 9.64 (s, 1H); 13C NMR
(75 MHz, DMSO-d6): ı (ppm) 22.6, 47.3, 118.0, 118.2, 123.5, 124.5,
126.9, 127.8, 127.9, 128.6, 129.1, 129.6, 130.2, 130.9, 131.8, 131.9,
143.6, 148.9, 169.7.
NMR (75 MHz, DMSO-d6): ı (ppm) 23.0, 48.4, 118.6, 118.8, 122.9,
123.5, 126.3, 127.1, 128.9, 129.1, 129.9, 130.1, 132.7, 134.9, 150.6,
153.7, 170.1, 193.1; MS: m/z = 319.2 (M+).
4. Conclusions
In conclusion, we have introduced a highly efficient and
homogenous organic catalyst for the one-pot three-component
Ritter type reaction of 2-naphthol, various arylaldehydes and ace-
tonitrile. The promising points for the presented methodology are
efficiency, generality, high yield, short reaction time, extremely
mild reaction conditions, cleaner reaction profile and simplicity
which makes it a useful and attractive process for the synthesis of
1-amidoalkyl-2-naphthoils as biologically interesting compounds.
3.3.13. N-[(2-Hydroxynaphthalen-1-yl)(4-
bromophenyl)methyl]acetamide (1m)
White solid; mp 226–228 ◦C (lit. [23] 227–229 ◦C); 1H NMR
(300 MHz, DMSO-d6): ı (ppm) 1.98 (s, 3H), 6.98–7.34 (m, 8H),
7.61–7.67 (m, 2H), 7.86 (d, J = 10.1, 1H), 8.27 (d, J = 8.1 Hz, 1H), 9.74
(s, 1H); 13C NMR (75 MHz, DMSO-d6): ı (ppm) 23.7, 46.5, 117.8,
118.7, 121.2, 122.4, 123.8, 126.9, 128.4, 128.7, 129.3, 130.2, 131.0,
133.2, 139.8, 152.6, 168.4.
Acknowledgements
3.3.14. N-[(2-Hydroxynaphthalen-1-yl)(4-
The authors gratefully acknowledge partial support of this work
by the Research Affairs Office of Bu-Ali Sina University (Grant num-
ber 32-1716 entitled development of chemical methods, reagent
and molecules), Center of Excellence in Development of Chemical
Method (CEDCM), Hamedan, I.R Iran.
fluorophenyl)methyl]acetamide (1n)
White solid; mp 201–204 ◦C (lit. [24] 203–205 ◦C); 1H NMR
(300 MHz, DMSO-d6): ı (ppm) 2.05 (s, 3H), 7.11 (m, 2H), 7.18–7.35
(m, 5H), 7.65–7.78 (m, 4H), 8.46 (d, J = 7.9 Hz, 1H), 9.87 (s, 1H); 13
C
NMR (75 MHz, DMSO-d6): ı (ppm) 23.5, 47.1, 115.1, 117.9, 118.3,
121.4, 123.0, 126.1, 127.5, 128.0, 128.3, 128.9, 130.9, 137.1, 152.8,
160.1, 168.0.
References
[1] T. Dingermann, D. Steinhilber, G. Folkers, Molecular Biology in Medicinal Chem-
istry, Wiley-VCH, Weinheim, 2004.
[2] A.Y. Shen, C.T. Tsai, C.L. Chen, Eur. J. Med. Chem. 34 (1999) 877–882.
[3] A.Y. Shen, C.L. Chen, C.I. Lin, Chin. J. Physiol. 35 (1992) 45–54.
[4] M. Damodiran, N.P. Selvam, P.T. Perumal, Tetrahedron Lett. 50 (2009)
5474–5478.
[5] T. Haneishi, T. Okazaki, T. Hata, C. Tamura, M. Nomura, A. Naito, I. Seki, M. Arai,
J. Antibiot. 24 (1971) 797–799.
[6] K. Sasaki, Y. Kusakabe, S. Esumi, J. Antibiot. 25 (1972) 151–154.
[7] Y. Kusakabe, J. Nagatsu, M. Shibuya, O. Kawaguchi, C. Hirose, S. Shirato, J.
Antibiot. 25 (1972) 44–47.
3.3.15. N-[(2-Hydroxynaphthalen-1-yl)(2,4-
dichlorophenyl)methyl]acetamide (1o)
White solid; mp 196–198 ◦C (lit. [23] 198–199 ◦C); 1H NMR
(300 MHz, DMSO-d6): ı (ppm) 1.96 (s, 3H), 6.99–7.10 (m, 2H),
7.26–7.38 (m, 4H), 7.59 (d, J = 8.4 Hz, 1H), 7.73–7.79 (m, 2H), 7.95 (d,
J = 8.5 Hz, 1H), 7.64 (d, J = 8.1 Hz, 1H), 9.87 (s, 1H); 13C NMR (75 MHz,
DMSO-d6): ı (ppm) 23.1, 48.4, 117.3, 118.6, 122.8, 123.2, 127.6,
127.8, 129.4, 129.8, 130.2, 131.4, 132.5, 132.9, 133.4, 134.1, 140.7,
152.9, 168.7.
[8] M.C. Wani, H.L. Taylor, M.E. Wall, J. Chem. Soc., Chem. Commun. (1973) 390.
[9] P.Y. Johnson, R.B. Silver, J. Heterocycl. Chem. 10 (1973) 1029–1030.
[10] S. Remillard, L.I. Rebhun, G.A. Howie, S.M. Kupchan, Science 189 (1975)
1002–1005.
[11] T. Urban´ ski, D. Ghrne, I. Szczerek, M. Modaski, Polish Patent, 54 (1967) 007.
[12] G.Y. Lesher, A.R. Surrey, J. Am. Chem. Soc. 77 (1955) 636–641.
[13] H.S. Mosher, M.B. Frankel, M. Gregory, J. Am. Chem. Soc. 75 (1953) 5326–
5328.
[14] J.L. Peglion, J. Vian, B. Gourment, N. Despaux, V. Audinot, M. Millan, Bioorg. Med.
Chem. Lett. 7 (1997) 881–886.
[15] H. Ren, S. Grady, D. Gamenara, H. Heinzen, P. Moyna, S. Croft, H. Kendrick, V.
Yardley, G. Moyna, Bioorg. Med. Chem. Lett. 11 (2001) 1851–1854.
[16] F. Benedini, G. Bertolini, R. Cereda, G. Doná, G. Gromo, S. Levi, J. Mizrahi, A. Sala,
J. Med. Chem. 38 (1995) 130–136.
[17] R.D. Clark, J.M. Caroon, A.F. Kluge, D.B. Repke, A.P. Roszkowski, A.M. Strosberg,
S. Baker, S.M. Bitter, M.D. Okada, J. Med. Chem. 26 (1983) 657–661.
[18] H. Matsuoka, N. Ohi, M. Mihara, H. Suzuki, K. Miyamoto, N. Maruyama, K. Tsuji,
N. Kato, T. Akimoto, Y. Takeda, K. Yano, T. Kuroki, J. Med. Chem. 40 (1997)
105–111.
3.3.16.
N-[{4-[Acetylamino-(2-hydroxy-naphthalen-1-yl)-methyl]-
phenyl}-(2-hydroxy-naphthalen-1-yl)-methyl]acetamide (2a)
White solid; mp 277–279 ◦C; IR (KBr): 3402, 3192, 3059, 1644,
1583, 1478, 1275, 816 cm−1 1H NMR (300 MHz, DMSO-d6): ı
;
(ppm) 2.01 (s, 6H), 7.17–7.39 (m, 12H), 7.77–7.93 (m, 6H), 8.53
(d, J = 8.2 Hz, 2H), 10.09 (s, 2H); 13C NMR (75 MHz, DMSO-d6): ı
(ppm) 23.1, 48.2, 118.9, 119.2, 122.8, 126.3, 126.8, 128.9, 129.0,
129.6, 132.7, 140.8, 140.9, 153.6, 169.7; MS: m/z = 504.5 (M+); Anal.
calcd. for C32H28N2O4: C, 76.17; H, 5.59; N, 5.55. Found: C, 76.43;
H, 5.70; N, 5.47.
[19] N.P. Selvam, P.T. Perumal, Tetrahedron Lett. 47 (2006) 7481–7483.
[20] M.M. Khodaei, A.R. Khosropour, H. Moghanian, Synlett (2006) 916–920.
[21] B. Das, K. Laxminarayana, B. Ravikanth, B.R. Rao, J. Mol. Catal. A: Chem. 261
(2007) 180–183.
[22] S.B. Patil, P.R. Singh, M.P. Surpur, S.D. Samant, Synth. Commun. 37 (2007)
1659–1664.
[23] H.R. Shaterian, H. Yarahmadi, M. Ghashang, Bioorg. Med. Chem. Lett. 18 (2008)
788–792.
[24] S.B. Patil, P.R. Singh, M.P. Surpur, S.D. Samant, Ultrason. Sonochem. 14 (2007)
515–518.
3.3.17. N-[(4-Diethoxymethyl-phenyl)-(2-hydroxy-naphthalen-
1-yl)-methyl]acetamide (2b)
Pale yellow solid; mp 173–175 ◦C; IR (KBr): 3400, 3181, 3057,
1665, 1589, 1507, 1276, 812 cm−1 1H NMR (300 MHz, DMSO-d6):
;
ı (ppm) 1.17 (t, J = 6.9 Hz, 6H), 2.02 (s, 3H), 3.58 (q, J = 6.9 Hz, 4H),
6.96–7.46 (m, 9H), 7.73–7.85 (m, 3H), 8.26 (d, J = 8.5 Hz, 1H,), 10.22
(s, 1H); 13C NMR (75 MHz, DMSO-d6): ı (ppm) 19.1, 23.2, 48.5, 56.7,
111.8, 119.1, 119.6, 120.9, 122.7, 124.5, 126.2, 128.5, 129.1, 129.7,
132.9, 134.8, 139.7, 142.4, 153.3, 169.9; MS: m/z = 393.3 (M+); Anal.
calcd. for C24H27NO4: C, 73.26; H, 6.92; N, 3.56. Found: C, 73.09; H,
7.01; N, 3.62.
[25] H.R. Shaterian, H. Yarahmadi, M. Ghashang, Tetrahedron 64 (2008) 1263–1269.
[26] H.R. Shaterian, H. Yarahmadi, ARKIVOC ii (2008) 105–114.
[27] L. Nagarapu, M. Baseeruddin, S. Apuri, S. Kantevari, Catal. Commun. 8 (2007)
1729–1734.
[28] A. Dorehgiraee, H. Khabazzade, K. Saidi, ARKIVOC vii (2009) 303–310.